Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 220

1.

A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.

March JS, Entusah AR, Rynn M, Albano AM, Tourian KA.

Biol Psychiatry. 2007 Nov 15;62(10):1149-54. Epub 2007 Jun 5.

PMID:
17553467
[PubMed - indexed for MEDLINE]
2.

Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.

Katz IR, Reynolds CF 3rd, Alexopoulos GS, Hackett D.

J Am Geriatr Soc. 2002 Jan;50(1):18-25.

PMID:
12028242
[PubMed - indexed for MEDLINE]
3.

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E.

JAMA. 2000 Jun 21;283(23):3082-8.

PMID:
10865302
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.

Rynn MA, Riddle MA, Yeung PP, Kunz NR.

Am J Psychiatry. 2007 Feb;164(2):290-300.

PMID:
17267793
[PubMed - indexed for MEDLINE]
5.

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.

Allgulander C, Mangano R, Zhang J, Dahl AA, Lepola U, Sjödin I, Emilien G; SAD 388 Study Group.

Hum Psychopharmacol. 2004 Aug;19(6):387-96.

PMID:
15303242
[PubMed - indexed for MEDLINE]
6.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
[PubMed - indexed for MEDLINE]
7.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
[PubMed - indexed for MEDLINE]
8.

A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

Liebowitz MR, Mangano RM, Bradwejn J, Asnis G; SAD Study Group.

J Clin Psychiatry. 2005 Feb;66(2):238-47.

PMID:
15705011
[PubMed - indexed for MEDLINE]
9.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
10.

Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.

Bose A, Korotzer A, Gommoll C, Li D.

Depress Anxiety. 2008;25(10):854-61.

PMID:
18050245
[PubMed - indexed for MEDLINE]
11.

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Stein MB, Pollack MH, Bystritsky A, Kelsey JE, Mangano RM.

Psychopharmacology (Berl). 2005 Jan;177(3):280-8. Epub 2004 Jul 16.

PMID:
15258718
[PubMed - indexed for MEDLINE]
12.

A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.

Rickels K, Mangano R, Khan A.

J Clin Psychopharmacol. 2004 Oct;24(5):488-96.

PMID:
15349004
[PubMed - indexed for MEDLINE]
13.

Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.

Kroenke K, Messina N 3rd, Benattia I, Graepel J, Musgnung J.

J Clin Psychiatry. 2006 Jan;67(1):72-80.

PMID:
16426091
[PubMed - indexed for MEDLINE]
14.

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

Rickels K, Pollack MH, Sheehan DV, Haskins JT.

Am J Psychiatry. 2000 Jun;157(6):968-74.

PMID:
10831478
[PubMed - indexed for MEDLINE]
15.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
[PubMed - indexed for MEDLINE]
16.

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.

Arch Gen Psychiatry. 2006 Oct;63(10):1158-65.

PMID:
17015818
[PubMed - indexed for MEDLINE]
17.

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.

Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y.

J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):479-88.

PMID:
17420682
[PubMed - indexed for MEDLINE]
18.

Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.

Davidson J, Rothbaum BO, Tucker P, Asnis G, Benattia I, Musgnung JJ.

J Clin Psychopharmacol. 2006 Jun;26(3):259-67. Erratum in: J Clin Psychopharmacol. 2006 Oct;26(5):473. Dosage error in article text.

PMID:
16702890
[PubMed - indexed for MEDLINE]
19.

Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

Nimatoudis I, Zissis NP, Kogeorgos J, Theodoropoulou S, Vidalis A, Kaprinis G.

Int Clin Psychopharmacol. 2004 Nov;19(6):331-6.

PMID:
15486518
[PubMed - indexed for MEDLINE]
20.

A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.

Lenox-Smith AJ, Reynolds A.

Br J Gen Pract. 2003 Oct;53(495):772-7.

PMID:
14601352
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk